GP registrars carry enormous responsibility with limited experience. AusDoc research reveals 5 practical ways pharma can support registrar confidence and build early HCP relationships.
Read more6 key messages you should prioritise when talking to GPs about your product
AusDoc research reveals what Australian GPs actually want from pharma — 6 priority messages that cut through information overload and drive meaningful HCP engagement.
Read more5 key insights to better understand and engage with medical students
Survey uncovers what medical students need and how best to connect with them Helping medical students to succeed in their studies is a key factor in getting their attention, a recent ADG survey* has found. The survey, conducted in February 2021, asked students in their final two years of study about the tensions they face and what they need
Read moreHow has COVID-19 changed GP and pharmaceutical field staff engagement?
With the sudden and dramatic impact of COVID-19, a survey of GPs and their contact with pharmaceutical field staff during the pandemic reveals a massive drop in face-to-face engagement. The joint Australian Doctor Group and Medicines Australia poll was sent out in mid-May and attracted almost 400 responders. It shows prior to the pandemic half
Read moreCOVID-19: Is it time for governments to start a conversation with GPs?
As Australia enters a new phase of its COVID-19 journey, governments have an increasing opportunity to engage in a two-way conversation with GPs; not only about the virus itself but also about ensuring their patients don’t ignore their general health during the pandemic. GPs are generally satisfied with the COVID-19 information they have received up to now, according to a survey of AusDoc.PLUS readers1. But a big gripe is that different information sources
Read moreHow has COVID-19 changed GP digital engagement?
To download a PDF version of this infographic, please click here.
Read morePharma’s role in the COVID-19 crisis goes beyond new tests and treatments
During COVID-19, pharma’s role extended far beyond new treatments. How the industry’s broader support for Australian GPs reshaped trust and transformed HCP engagement models.
Read moreTelehealth and quality care: How COVID-19 is rapidly changing the GP landscape
COVID-19 accelerated telehealth adoption across Australian general practice almost overnight. Explore what this shift means for pharma engagement and digital HCP marketing strategy.
Read moreADG’s response to COVID-19
How Australian Doctor Group responded to COVID-19 — keeping GPs and the healthcare community informed through Australia’s #1 independent medical platform during the pandemic.
Read moreADG dominates with No.1 position in latest GP readership results
ADG retains #1 in GP digital and print reach with 48.4% of Australian GPs visiting AusDoc monthly — essential proof-point data for pharma media planning and HCP campaigns.
Read more